Learning Objectives: -Explain treatment options including an overview of the latest developments in therapy -Identify patients who are candidates for newly approved therapies including BTK inhibitors, alone or in combination, and CAR T-cell therapy -Explain the HCP s role in preparing the patient for therapy, administering treatment, monitoring for and managing side effects -Discuss long-term follow up and survivorship care planning
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 40946 US Highway 19 N
Pricing
CME included with membership · $19.99/mo
| Regular Membership | Free |
| Affiliated Health Professional Membership | Free |
| MENASA Group Explorer | Free |
| MENASA Group Elite Member | $19.99/mo |
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Neuroradiology
- Ophthalmology
- Patient Education & Health Literacy
- Pediatric Gastroenterology
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Thoracic Surgery
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedDec 9, 2025
-
Last day to claim creditDec 18, 2026 2 months left
-
Partners for Advancing Clinical Education An Evolving Standard of Care in Chronic Lymphocytic Leukemia: Patient Perspectives and Clinical Insights on Novel Therapeutic Strategies Across the Disease Continuum
-
CLL Society +1 CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies
-
Efficient CME, CME Outfitters, LLC Evidence in Action: Using Expert Insights and Practice Patterns to Guide Optimal Treatment of Chronic Lymphocytic Leukemia
-
Society of Hematologic Oncology +1 Relapsed/Refractory CLL/SLL Clinical Insights: Navigating Novel Therapy Integration and Sequencing Considerations – Mobile Microlearning
-
Medical Learning Institute, Inc. Expert Exchanges on the Evolving Treatment Landscape of Acute Lymphoblastic Leukemia
-
Blood Cancer United +1 Inside Myeloma Rounds: Expert Discussion and Updates
